How have IDH shares performed in 2024?

Immunodiagnostic Systems' stock was trading at GBX 378 at the start of the year. Since then, IDH stock has increased by 0.0% and is now trading at GBX 378. View the best growth stocks for 2024 here .

How were Immunodiagnostic Systems' earnings last quarter?

Immunodiagnostic Systems Holdings PLC (LON:IDH) posted its quarterly earnings data on Wednesday, June, 20th. The company reported $5.70 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.60 by $3.10.

Is Immunodiagnostic Systems a good dividend stock?

Immunodiagnostic Systems (LON:IDH) pays an annual dividend of GBX 0.02 per share and currently has a dividend yield of 0.50%. The dividend payout ratio is 1.46%. This payout ratio is at a healthy, sustainable level, below 75%. Read our dividend analysis for IDH .

What other stocks do shareholders of Immunodiagnostic Systems own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Immunodiagnostic Systems investors own include Dechra Pharmaceuticals (DPH) , iShares Biotechnology ETF (IBB) , Redrow (RDW) , Netflix (NFLX) , Sysco (SYY) , TP ICAP Group (TCAP) , Telford Homes (TEF) , WisdomTree U.S. Multifactor Fund (USMF) , American Tower (AMT) and Advanced Medical Solutions Group (AMS) .

How do I buy shares of Immunodiagnostic Systems?

Shares of IDH stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. Compare Top Brokerages Here .

LON:IDH

Immunodiagnostic Systems (IDH) Share Price, News & Analysis

→ New crypto project uncovers 2,050% in 65 days (From InvestorPlace) (Ad)

Free IDH Stock Alerts

GBX 378

0.00 (0.00%)

(As of 07/12/2021)

Compare

Today's Range: 378
▼
378
50-Day Range: 378
▼
378
52-Week Range: 180
▼
380

Volume: N/A
Average Volume: 14,539 shs
Market Capitalization: £108.80 million

P/E Ratio: 290.77
Dividend Yield: 0.01%
Price Target: N/A

Stock Analysis

Get Immunodiagnostic Systems alerts:

Ad InvestorPlace

New crypto project uncovers 2,050% in 65 days

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

Just click here to sign up and be among the first to get it.

About Immunodiagnostic Systems Stock (LON:IDH)

Immunodiagnostic Systems Holdings PLC develops, manufactures, and sells in-vitro diagnostic tests to the clinical laboratory market in the United Kingdom, the United States, Germany, France, and internationally. It develops, manufactures, and markets immunoassays and automated immunoanalyser technologies to provide diagnostic outcomes for patients. It offers IDS-iSYS multi-discipline automated systems, which is based on chemiluminescence and absorbency technology is used for immunoassay testing. The company provides its products and services for diagnosis of bone metabolism, calcium metabolism, hypertension, chronic kidney disease mineral bone disorder, growth, fertility, autoimmunity, infectious disease, sarcoidosis, and allergy. Immunodiagnostic Systems Holdings PLC was founded in 1977 and is headquartered in Boldon, the United Kingdom.

IDH Stock Price History

30 days | 90 days | 365 days | Advanced Chart

IDH Stock News Headlines

March 25, 2024 | markets.businessinsider.com

EQS-News: DATAGROUP Acquires ISC Innovative Systems Consulting AG

March 21, 2024 | msn.com

2025 Volkswagen ID.7 First Drive Review: Okay, I Get It Now

April 19, 2024 | InvestorPlace (Ad)

New crypto project uncovers 2,050% in 65 days

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

March 21, 2024 | msn.com

Volkswagen ID.4 Makes Debut In India, Set To Hit Roads Soon

August 8, 2023 | msn.com

Farewell, Fake IDs: Age Verification Gets an Upgrade

June 26, 2023 | msn.com

Revenues and profits rise at Immunodiagnostic Systems in year after £110m takeover

June 20, 2023 | lse.co.uk

IDH.L Regulatory News

June 9, 2023 | finanznachrichten.de

Immunohistochemistry (IHC) Market worth $4.7 billion | MarketsandMarkets

April 19, 2024 | InvestorPlace (Ad)

New crypto project uncovers 2,050% in 65 days

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

May 13, 2023 | forbes.com

10 Best Leave Management Systems In 2023

April 8, 2023 | marketwatch.com

2023-2029 Immunodiagnostic Equipment Market Share and Growth Opportunities | Report by Industry Experts

February 23, 2023 | forbes.com

Epic Systems

February 18, 2023 | marketwatch.com

Veterinary Immunodiagnostic Device Market Analysis Report 2023 Along with Statistics Figures, till 2029

See More Headlines

Receive IDH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Immunodiagnostic Systems and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 6/20/2018
Today: 4/19/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: LON
Sector: Medical
Industry: Medical Appliances & Equipment
Sub-Industry: N/A
Current Symbol: LON:IDH
CUSIP: N/A
CIK: N/A
Web: www.idsplc.com
Phone: +44-191-5190660
Fax: N/A
Employees: 147,000
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: 290.77
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: 6.84
Current Ratio: 5.40
Quick Ratio: 3.87

Sales & Book Value

Annual Sales: £34.25 million
Price / Sales: 3.18
Cash Flow: GBX 84 per share
Price / Cash Flow: 4.50
Book Value: GBX 187.60 per share
Price / Book: 2.01

Miscellaneous

Outstanding Shares: 28,784,000
Free Float: N/A
Market Cap: £108.80 million
Optionable: Not Optionable
Beta: N/A

7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

Key Executives

Mr. Jaap Stuut (Age 51)
CEO & Director
Comp: $284k
Mr. Paul J. Martin
Group Fin. Director, Company Sec. & Director
Mr. Sander Perret Gentil
Head of Marketing & Communications
Nicola Mitton
Group HR Director
Mr. Ed Coombes (Age 50)
Head Of Bus. Devel. - Instrumentation
Dr. Rudolf Schemer Ph.D. (Age 60)
CEO of GeschTMaftsfuhrer at IDS GmbH Frankfurt & Country Mang. of Germany Region

Key Competitors

View All Competitors

IDH Stock Analysis - Frequently Asked Questions

How have IDH shares performed in 2024?: Immunodiagnostic Systems' stock was trading at GBX 378 at the start of the year. Since then, IDH stock has increased by 0.0% and is now trading at GBX 378.
View the best growth stocks for 2024 here.
How were Immunodiagnostic Systems' earnings last quarter?: Immunodiagnostic Systems Holdings PLC (LON:IDH) posted its quarterly earnings data on Wednesday, June, 20th. The company reported $5.70 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.60 by $3.10.
Is Immunodiagnostic Systems a good dividend stock?: Immunodiagnostic Systems (LON:IDH) pays an annual dividend of GBX 0.02 per share and currently has a dividend yield of 0.50%. The dividend payout ratio is 1.46%. This payout ratio is at a healthy, sustainable level, below 75%.
Read our dividend analysis for IDH.

What other stocks do shareholders of Immunodiagnostic Systems own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Immunodiagnostic Systems investors own include Dechra Pharmaceuticals (DPH), iShares Biotechnology ETF (IBB), Redrow (RDW), Netflix (NFLX), Sysco (SYY), TP ICAP Group (TCAP), Telford Homes (TEF), WisdomTree U.S. Multifactor Fund (USMF), American Tower (AMT) and Advanced Medical Solutions Group (AMS).
How do I buy shares of Immunodiagnostic Systems?: Shares of IDH stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

This page (LON:IDH) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Immunodiagnostic Systems (IDH) Share Price, News & Analysis

About Immunodiagnostic Systems Stock (LON:IDH)

IDH Stock Price History

IDH Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

IDH Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info